Crossmark

Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-022-10086-5

Published Online: 2022-09-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Tian-Tian

Shan, Jia-Hui

Yang, Yu-Xian

Zhang, Ze-Wei

Liu, Shi-Liang

Xi, Mian

Liu, Meng-Zhong

Zhao, Lei
License Information

Text and Data Mining valid from 2022-09-17

Version of Record valid from 2022-09-17
More Information

Article History

Received: 20 July 2022

Accepted: 13 September 2022

First Online: 17 September 2022

Declarations

:

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below